Shiloh
Editor, Senior Moderator
Source: https://www.cbc.ca/news/health/cana...ts-astrazeneca-oxford-vaccine-vipit-1.5985755
Canada confirms 1st case of rare blood clot after AstraZeneca COVID-19 vaccine
Health officials say woman is first case of VIPIT after vaccine in Canada and is recovering at home
Adam Miller ? CBC News ? Posted: Apr 13, 2021 7:09 PM ET | Last Updated: 2 hours ago
The first confirmed case of a rare but potentially fatal blood clot has been recorded in Canada in connection with the AstraZeneca-Oxford COVID-19 vaccine.
Quebec's Ministry of Health and Social Services confirmed a person in the province experienced an adverse event known as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).
The ministry didn't confirm the age or gender of the person, but Quebec Health Minister Christian Dub? later identified the individual as a woman.
"The good news is, the woman in question was taken care of and she's doing well," he said during a news conference Tuesday.
The National Advisory Committee on Immunization (NACI) said last month VIPIT occurs at a rate of about one in 100,000 people vaccinated, with a mortality rate of about 40 per cent, although more research is needed and that risk is reduced if treated early enough.
Dub? said the province is taking a "hypervigilant" approach and keeping a close eye on any adverse reactions related to the vaccine. He said this was a possibility that health officials "expected" and prepared for...
Canada confirms 1st case of rare blood clot after AstraZeneca COVID-19 vaccine
Health officials say woman is first case of VIPIT after vaccine in Canada and is recovering at home
Adam Miller ? CBC News ? Posted: Apr 13, 2021 7:09 PM ET | Last Updated: 2 hours ago
The first confirmed case of a rare but potentially fatal blood clot has been recorded in Canada in connection with the AstraZeneca-Oxford COVID-19 vaccine.
Quebec's Ministry of Health and Social Services confirmed a person in the province experienced an adverse event known as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).
The ministry didn't confirm the age or gender of the person, but Quebec Health Minister Christian Dub? later identified the individual as a woman.
"The good news is, the woman in question was taken care of and she's doing well," he said during a news conference Tuesday.
The National Advisory Committee on Immunization (NACI) said last month VIPIT occurs at a rate of about one in 100,000 people vaccinated, with a mortality rate of about 40 per cent, although more research is needed and that risk is reduced if treated early enough.
Dub? said the province is taking a "hypervigilant" approach and keeping a close eye on any adverse reactions related to the vaccine. He said this was a possibility that health officials "expected" and prepared for...